Literature DB >> 20972954

Prediction of common bile duct stones in the earliest stages of acute biliary pancreatitis.

H C van Santvoort1, O J Bakker, M G Besselink, T L Bollen, K Fischer, V B Nieuwenhuijs, H G Gooszen, K J Erpecum.   

Abstract

BACKGROUND AND STUDY AIMS: Accurate prediction of common bile duct (CBD) stones in acute biliary pancreatitis is warranted to select patients for early therapeutic endoscopic retrograde cholangiopancreatography (ERCP). We evaluated commonly used biochemical and radiological predictors of CBD stones in a large prospective cohort of patients with acute biliary pancreatitis who were undergoing early ERCP. PATIENTS AND METHODS: 167 patients with acute biliary pancreatitis who were undergoing early ERCP (< 72 hours after symptom onset) in 15 Dutch hospitals in 2004 - 2007 were prospectively included. Abdominal ultrasonography and/or computed tomography (CT) was performed on admission and complete liver biochemistry determined daily. We used univariate logistic regression to assess associations between CBD stones found during ERCP (gold standard) and the following parameters: (1) clinical: age, sex, predicted severity; (2) radiological: dilated CBD, impacted stone in CBD; and (3) biochemical: bilirubin, γ-glutamyltransferase (GGT), alkaline phosphatase, alanine aminotransferase (ALT), and aspartate aminotransferase (AST).
RESULTS: Out of 167 patients, 94 (56 %) had predicted severe acute biliary pancreatitis, 51 (31%) exhibited a dilated CBD and 15 (9%) had CBD stones on ultrasonography and/or CT. ERCP was performed at a median of 0 days (interquartile range 0 - 1) after admission. CBD stones were found during ERCP in 89/167 patients (53%). In univariate analysis, the only parameters significantly associated with CBD stones were GGT (per 10 units increase: odds ratio 1.02, 95% CI 1.01 - 1.03, P = 0.001) and alkaline phosphatase (per 10 units increase: odds ratio 1.03, 95% CI 1.00 - 1.05, P = 0.028). These and all other tested parameters, however, showed poor positive predictive value (ranging from 0.53 to 0.69) and poor negative predictive value (ranging from 0.46 to 0.67).
CONCLUSIONS: The results of this study suggest that commonly used biochemical and radiological predictors of the presence of CBD stones during ERCP in the earliest stages of acute biliary pancreatitis are unreliable. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20972954     DOI: 10.1055/s-0030-1255866

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  8 in total

Review 1.  Role and timing of endoscopy in acute biliary pancreatitis.

Authors:  Andrea Anderloni; Alessandro Repici
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

2.  Dynamic analysis of commonly used biochemical parameters to predict common bile duct stones in patients undergoing laparoscopic cholecystectomy.

Authors:  Stéphane Bourgouin; Xavier Truchet; Gatien Lamblin; Jérôme De Roulhac; Jean-Philippe Platel; Paul Balandraud
Journal:  Surg Endosc       Date:  2017-04-13       Impact factor: 4.584

3.  Are liver function tests, pancreatitis and cholecystitis predictors of common bile duct stones? Results of a prospective, population-based, cohort study of 1171 patients undergoing cholecystectomy.

Authors:  Per Videhult; Gabriel Sandblom; Claes Rudberg; Ib Christian Rasmussen
Journal:  HPB (Oxford)       Date:  2011-05-11       Impact factor: 3.647

4.  Early endoscopic ultrasonography in acute biliary pancreatitis: A prospective pilot study.

Authors:  Andrea Anderloni; Marianna Galeazzi; Marco Ballarè; Michela Pagliarulo; Marco Orsello; Mario Del Piano; Alessandro Repici
Journal:  World J Gastroenterol       Date:  2015-09-28       Impact factor: 5.742

Review 5.  Ultrasound versus liver function tests for diagnosis of common bile duct stones.

Authors:  Kurinchi Selvan Gurusamy; Vanja Giljaca; Yemisi Takwoingi; David Higgie; Goran Poropat; Davor Štimac; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2015-02-26

6.  Scoring System for the Management of Acute Gallstone Pancreatitis: Cost Analysis of a Prospective Study.

Authors:  Jake G Prigoff; Gary W Swain; Celia M Divino
Journal:  J Gastrointest Surg       Date:  2016-03-21       Impact factor: 3.452

7.  Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.

Authors:  Nicolien J Schepers; Olaf J Bakker; Marc G H Besselink; Thomas L Bollen; Marcel G W Dijkgraaf; Casper H J van Eijck; Paul Fockens; Erwin J M van Geenen; Janneke van Grinsven; Nora D L Hallensleben; Bettina E Hansen; Hjalmar C van Santvoort; Robin Timmer; Marie-Paule G F Anten; Clemens J M Bolwerk; Foke van Delft; Hendrik M van Dullemen; G Willemien Erkelens; Jeanin E van Hooft; Robert Laheij; René W M van der Hulst; Jeroen M Jansen; Frank J G M Kubben; Sjoerd D Kuiken; Lars E Perk; Rogier J J de Ridder; Marno C M Rijk; Tessa E H Römkens; Erik J Schoon; Matthijs P Schwartz; B W Marcel Spanier; Adriaan C I T L Tan; Willem J Thijs; Niels G Venneman; Frank P Vleggaar; Wim van de Vrie; Ben J Witteman; Hein G Gooszen; Marco J Bruno
Journal:  Trials       Date:  2016-01-05       Impact factor: 2.279

8.  Pancreatic necrosis and severity are independent risk factors for pancreatic endocrine insufficiency after acute pancreatitis: A long-term follow-up study.

Authors:  Bing-Jun Yu; Nian-Shuang Li; Wen-Hua He; Cong He; Jian-Hua Wan; Yin Zhu; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2020-06-21       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.